Companies
Kenvue
Consumer goodsSummit, New JerseyKVUEAbout 22,000 employees
More about Kenvue
Consumer health company selling over-the-counter medicines, skin care and personal care products, spun off from Johnson & Johnson in 2023
Revenue
$15.1B
2025, down 2.1%
Employees
About 22,000
As of December 2025
Stock
KVUE
New York Stock Exchange
Headquarters
Summit, New Jersey
CEO
Kirk Perry
Since November 2025; interim CEO from July 2025
BrandsTylenol, Neutrogena, Listerine, Band-Aid, Aveeno, Johnson's, Zyrtec
Current strategyAgreed in November 2025 to be acquired by Kimberly-Clark, with closing expected in the fourth quarter of 2026, while simplifying its operating model and supply chain
Recent workforce changesNet global workforce reduction of about 3.5% approved in February 2026
CompetitorsHaleon, Procter & Gamble, Bayer
Related companiesKimberly-ClarkJohnson & JohnsonProcter & Gamble
Checked October 11, 2026 · Sources: sec.gov, sec.gov (2), sec.gov (3), sec.gov (4)
Be the first to post about Kenvue
No one has started a discussion here yet. Yours is anonymous and appears right away, and we don’t store who wrote it.
Or follow Kenvue to see the first post in your watchlist.
Follow Kenvue in a feed reader, no account needed: RSS feed